Archis Pharma LLC
Archis Pharma LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in innovative drug development and manufacturing. Founded in 2008, the company has established itself as a leader in providing high-quality pharmaceutical products, particularly in the areas of oncology and rare diseases. With a commitment to advancing healthcare, Archis Pharma offers a unique portfolio of services, including custom synthesis and formulation development, tailored to meet the specific needs of its clients. The company’s focus on quality and regulatory compliance has earned it a strong market position, recognised for its contributions to improving patient outcomes. Through strategic partnerships and a dedication to research, Archis Pharma continues to drive innovation in the pharmaceutical landscape.
DitchCarbon Score
How does Archis Pharma LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Archis Pharma LLC's score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Archis Pharma LLC's reported carbon emissions
Archis Pharma LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Archis Pharma may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is unclear how Archis Pharma aligns with these industry trends. As the company moves forward, establishing measurable climate goals and reporting emissions could enhance its sustainability profile and contribute to broader environmental efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Archis Pharma LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
